Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects

Lignende værker

• Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
  af: Jenkins, H, et al.
  Udgivet: (2015)
• The binding selectivity of vonoprazan (TAK-438) to the gastric H(+),K(+)−ATPase
  af: Scott, David R., et al.
  Udgivet: (2015)
• Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole
  af: Ashida, Kiyoshi, et al.
  Udgivet: (2018)
• A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis
  af: Iwakiri, Katsuhiko, et al.
  Udgivet: (2017)
• Pharmacokinetic Drug–Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men
  af: Sakurai, Yuuichi, et al.
  Udgivet: (2016)